PROstate Multicentre External beam radioTHErapy Using a Stereotactic boost: the PROMETHEUS study protocol
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
PROstate Multicentre External beam radioTHErapy Using a Stereotactic boost: the PROMETHEUS study protocol ; volume:18 ; number:1 ; day:24 ; month:5 ; year:2018 ; pages:1-8 ; date:12.2018
BMC cancer ; 18, Heft 1 (24.5.2018), 1-8, 12.2018
- Urheber
-
Richardson, Matthew
- Beteiligte Personen und Organisationen
-
Sidhom, Mark
Gallagher, Sarah
Grand, Mel
Pryor, David
Bucci, Joseph
Wilton, Lee
Arumugam, Sankar
Keats, Sarah
Martin, Jarad M.
SpringerLink (Online service)
- DOI
-
10.1186/s12885-018-4511-6
- URN
-
urn:nbn:de:101:1-2018080423191305776926
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Richardson, Matthew
- Sidhom, Mark
- Gallagher, Sarah
- Grand, Mel
- Pryor, David
- Bucci, Joseph
- Wilton, Lee
- Arumugam, Sankar
- Keats, Sarah
- Martin, Jarad M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible
Prostate stereotactic body radiotherapy with simultaneous integrated boost: which is the best planning method?
Feasibility of a simultaneously integrated boost concept for hypofractionated stereotactic radiotherapy of unresected brain metastases
Successful Treatment of Adenoid Cystic Carcinoma with the Application of a High-Dose Stereotactic Body Radiotherapy Boost
Phase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR)
Whole brain radiotherapy versus stereotactic radiosurgery for 4–10 brain metastases: a phase III randomised multicentre trial
Phase I/II study of stereotactic body radiotherapy boost in patients with cervical cancer ineligible for intracavitary brachytherapy
High-dose stereotactic radiotherapy boost in the treatment of squamous cell carcinoma of the head and neck region
Predictors of Radiotherapy Induced Bone Injury (RIBI) after stereotactic lung radiotherapy
Online adaptive radiotherapy in stereotactic body radiotherapy for pancreatic cancer patients
Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment
Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial
Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible
Prostate stereotactic body radiotherapy with simultaneous integrated boost: which is the best planning method?
Feasibility of a simultaneously integrated boost concept for hypofractionated stereotactic radiotherapy of unresected brain metastases
Successful Treatment of Adenoid Cystic Carcinoma with the Application of a High-Dose Stereotactic Body Radiotherapy Boost
Phase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR)
Whole brain radiotherapy versus stereotactic radiosurgery for 4–10 brain metastases: a phase III randomised multicentre trial
Phase I/II study of stereotactic body radiotherapy boost in patients with cervical cancer ineligible for intracavitary brachytherapy
High-dose stereotactic radiotherapy boost in the treatment of squamous cell carcinoma of the head and neck region
Predictors of Radiotherapy Induced Bone Injury (RIBI) after stereotactic lung radiotherapy
Online adaptive radiotherapy in stereotactic body radiotherapy for pancreatic cancer patients
Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment
Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial
Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible
Prostate stereotactic body radiotherapy with simultaneous integrated boost: which is the best planning method?
Feasibility of a simultaneously integrated boost concept for hypofractionated stereotactic radiotherapy of unresected brain metastases
Successful Treatment of Adenoid Cystic Carcinoma with the Application of a High-Dose Stereotactic Body Radiotherapy Boost
Phase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR)
Whole brain radiotherapy versus stereotactic radiosurgery for 4–10 brain metastases: a phase III randomised multicentre trial
Phase I/II study of stereotactic body radiotherapy boost in patients with cervical cancer ineligible for intracavitary brachytherapy
High-dose stereotactic radiotherapy boost in the treatment of squamous cell carcinoma of the head and neck region
Predictors of Radiotherapy Induced Bone Injury (RIBI) after stereotactic lung radiotherapy
Online adaptive radiotherapy in stereotactic body radiotherapy for pancreatic cancer patients
Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment